TY - JOUR
T1 - Geographical variation in lung function
T2 - Results from the multicentric cross-sectional BOLD study
AU - Burney, Peter G J
AU - Potts, James
AU - Knox-Brown, Ben
AU - Erhabor, Gregory
AU - Hacene Cherkaski, Hamid
AU - Mortimer, Kevin
AU - Anand, Mahesh Padukudru
AU - Mannino, David M
AU - Cardoso, Joao
AU - Ahmed, Rana
AU - Elsony, Asma
AU - Barbara, Cristina
AU - Nielsen, Rune
AU - Bateman, Eric
AU - Paraguas, Stefanni Nonna M
AU - Cher Loh, Li
AU - Rashid, Abdul
AU - Wouters, Emiel Fm
AU - Franssen, Frits Me
AU - Dias, Hermínia Brites
AU - Gislason, Thorarinn
AU - Ghobain, Mohammed Al
AU - Biaze, Mohammed El
AU - Agarwal, Dhiraj
AU - Juvekar, Sanjay
AU - Rodrigues, Fatima
AU - Obaseki, Daniel O
AU - Koul, Parvaiz A
AU - Harrabi, Imed
AU - Nafees, Asaad A
AU - Seemungal, Terence
AU - Janson, Christer
AU - Vollmer, William M
AU - Amaral, Andre Fs
AU - Buist, A Sonia
PY - 2025/1
Y1 - 2025/1
N2 - Spirometry is used to determine what is "unusual" lung function compared with what is "usual" for healthy non-smokers. This study aimed to investigate regional variation in the forced vital capacity (FVC) and in the forced expiratory volume in one second to FVC ratio (FEV1/FVC) using cross-sectional data from all 41 sites of the multinational Burden of Obstructive Lung Disease study. Participants (5,368 men; 9,649 women), aged ≥40 years, had performed spirometry, had never smoked and reported no respiratory symptoms or diagnoses. To identify regions with similar FVC, we conducted a principal component analysis (PCA) on FVC with age, age2 and height2, separately for men and women. We regressed FVC against age, age2 and height2, and FEV1/FVC against age and height2, for each sex and site, stratified by region. Mean age was 54 years (both sexes), and mean height was 1.69 m (men) and 1.61 m (women). The PCA suggested four regions: 1) Europe and richer countries; 2) the Near East; 3) Africa; and 4) the Far East. For the FVC, there was little variation in the coefficients for age, or age2, but considerable variation in the constant (men: 2.97 L in the Far East to 4.08 L in Europe; women: 2.44 L in the Far East to 3.24 L in Europe) and the coefficient for height2. Regional differences in the constant and coefficients for FEV1/FVC were minimal (<1%). The relation of FVC with age, sex and height varies across and within regions. The same is not true for the FEV1/FVC ratio.
AB - Spirometry is used to determine what is "unusual" lung function compared with what is "usual" for healthy non-smokers. This study aimed to investigate regional variation in the forced vital capacity (FVC) and in the forced expiratory volume in one second to FVC ratio (FEV1/FVC) using cross-sectional data from all 41 sites of the multinational Burden of Obstructive Lung Disease study. Participants (5,368 men; 9,649 women), aged ≥40 years, had performed spirometry, had never smoked and reported no respiratory symptoms or diagnoses. To identify regions with similar FVC, we conducted a principal component analysis (PCA) on FVC with age, age2 and height2, separately for men and women. We regressed FVC against age, age2 and height2, and FEV1/FVC against age and height2, for each sex and site, stratified by region. Mean age was 54 years (both sexes), and mean height was 1.69 m (men) and 1.61 m (women). The PCA suggested four regions: 1) Europe and richer countries; 2) the Near East; 3) Africa; and 4) the Far East. For the FVC, there was little variation in the coefficients for age, or age2, but considerable variation in the constant (men: 2.97 L in the Far East to 4.08 L in Europe; women: 2.44 L in the Far East to 3.24 L in Europe) and the coefficient for height2. Regional differences in the constant and coefficients for FEV1/FVC were minimal (<1%). The relation of FVC with age, sex and height varies across and within regions. The same is not true for the FEV1/FVC ratio.
KW - Cross-sectional studies
KW - airflow obstruction
KW - forced expiratory volume
KW - forced vital capacity
KW - global health
KW - Humans
KW - Female
KW - Male
KW - Cross-Sectional Studies
KW - Middle Aged
KW - Vital Capacity/physiology
KW - Forced Expiratory Volume/physiology
KW - Spirometry/methods
KW - Adult
KW - Aged
KW - Europe/epidemiology
KW - Lung/physiopathology
KW - Africa/epidemiology
KW - Age Factors
KW - Principal Component Analysis
U2 - 10.1080/25310429.2024.2430491
DO - 10.1080/25310429.2024.2430491
M3 - Article
SN - 2531-0437
VL - 31
JO - Pulmonology
JF - Pulmonology
IS - 1
M1 - 2430491
ER -